Charah Solns's (NYSE:CHRA) short percent of float has fallen 32.2% since its last report. The company recently reported that it has 117 thousand shares sold short, which is 0.8% of all regular shares that are available for trading.
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Charah® Solutions, Inc. (NYSE:CHRA) ("Charah Solutions" or the "Company"), a leading provider of environmental services and byproduct recycling to the power generation industry, today